Translational Development Acquisition Stock (NASDAQ:TDAC)

Ownership Financials Chart

Previous Close

$10.82

52W Range

$10.35 - $10.95

50D Avg

$10.85

200D Avg

$10.67

Market Cap

$266.00M

Avg Vol (3M)

$28.30K

Beta

0.01

Div Yield

-

TDAC Company Profile

Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.

Industry

Shell Companies

Sector

Financial Services

Exchange

NASDAQ

ADR

-

Country

US

Employees

2

IPO Date

Feb 20, 2025

Website

TDAC Performance

TDAC Financial Summary

	Dec 25	Dec 24	Dec 23
Revenue	-	$1.07M	-
Operating Income	$-944.54K	$-196.36K	$-485.55K
Net Income	$6.36M	$-71.01K	$-485.55K
EBITDA	$-944.54K	$-71.01K	$-485.55K
Basic EPS	$0.37	$-0.02	$-0.12
Diluted EPS	$0.37	$-0.02	$-0.12

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

Ticker	Company
SZZL	Sizzle Acquisition Corp. II
HCMA	HCM III Acquisition Corp.
FACT	FACT II Acquisition Corp
MACI	Melar Acquisition Corp. I